121 related articles for article (PubMed ID: 7784252)
1. [125I]SNF 8702: a selective radioligand for CCKB receptors.
Slaninova J; Knapp RJ; Weber SJ; Davis TP; Fang SN; Hruby VJ; Yamamura HI
Peptides; 1995; 16(2):221-4. PubMed ID: 7784252
[TBL] [Abstract][Full Text] [Related]
2. A new, highly selective CCK-B receptor radioligand ([3H][N-methyl-Nle28,31]CCK26-33): evidence for CCK-B receptor heterogeneity.
Knapp RJ; Vaughn LK; Fang SN; Bogert CL; Yamamura MS; Hruby VJ; Yamamura HI
J Pharmacol Exp Ther; 1990 Dec; 255(3):1278-86. PubMed ID: 2262906
[TBL] [Abstract][Full Text] [Related]
3. [3H]pBC 264, a suitable probe for studying cholecystokinin-B receptors: binding characteristics in rodent brains and comparison with [3H]SNF 8702.
Durieux C; Ruiz-Gayo M; Corringer PJ; Bergeron F; Ducos B; Roques BP
Mol Pharmacol; 1992 Jun; 41(6):1089-95. PubMed ID: 1614411
[TBL] [Abstract][Full Text] [Related]
4. [3H]SNF8702 autoradiography of CCK-B receptors in guinea pig brain and studies with a cloned rat CCK-B receptor.
Knapp RJ; Malatynska E; Hashimoto S; Fang S; Hunt M; Wamsley JK; Peterson P; Zalewska T; Hruby VJ; Yamamura HI
Ann N Y Acad Sci; 1994 Mar; 713():380-3. PubMed ID: 8185194
[No Abstract] [Full Text] [Related]
5. Binding of cholecystokinin-8 (CCK-8) peptide derivatives to CCKA and CCKB receptors.
Schäfer U; Harhammer R; Boomgaarden M; Sohr R; Ott T; Henklein P; Repke H
J Neurochem; 1994 Apr; 62(4):1426-31. PubMed ID: 8133271
[TBL] [Abstract][Full Text] [Related]
6. Analysis of the behaviour of selected CCKB/gastrin receptor antagonists in radioligand binding assays performed in mouse and rat cerebral cortex.
Harper EA; Griffin EP; Shankley NP; Black JW
Br J Pharmacol; 1999 Mar; 126(6):1496-503. PubMed ID: 10217545
[TBL] [Abstract][Full Text] [Related]
7. Characterization of central cholecystokinin receptors using a radioiodinated octapeptide probe.
Wennogle LP; Steel DJ; Petrack B
Life Sci; 1985 Apr; 36(15):1485-92. PubMed ID: 2984502
[TBL] [Abstract][Full Text] [Related]
8. Cholecystokinin and gastrin are not equally sensitive to GTP gamma S at CCKB receptors: importance of the sulphated tyrosine.
Lallement JC; Oiry C; Lima-Leite AC; Lignon MF; Fulcrand P; Galleyrand JC; Martinez J
Eur J Pharmacol; 1995 Jul; 290(2):61-7. PubMed ID: 8575534
[TBL] [Abstract][Full Text] [Related]
9. Cholecystokinin receptor characterization and cholecystokinin-A receptor messenger RNA expression in transgenic mouse pancreatic carcinomas and dysplastic pancreas.
Povoski SP; Zhou W; Longnecker DS; Bell RH
Oncol Res; 1994; 6(9):411-7. PubMed ID: 7703527
[TBL] [Abstract][Full Text] [Related]
10. [N-methylnorleucine-(28,31)]cholecystokinin-(26-33) (SNF 8702) activity at a cloned rat CCKB receptor.
Knapp RJ; Malatynska E; Peterson P; Zalewska T; Fang S; Hruby VJ; Smith TL; Yamamura HI
Eur J Pharmacol; 1994 Oct; 269(2):133-8. PubMed ID: 7851490
[TBL] [Abstract][Full Text] [Related]
11. Cholecystokinin analogues with high affinity and selectivity for brain membrane receptors.
Hruby VJ; Fang SA; Knapp R; Kazmierski W; Lui GK; Yamamura HI
Int J Pept Protein Res; 1990 Jun; 35(6):566-73. PubMed ID: 2401597
[TBL] [Abstract][Full Text] [Related]
12. Study of the states and populations of the rat pancreatic cholecystokinin receptor using the full peptide antagonist JMV 179.
Silvente Poirot S; Hadjiivanova C; Escrieut C; Dufresne M; Martinez J; Vaysse N; Fourmy D
Eur J Biochem; 1993 Mar; 212(2):529-38. PubMed ID: 8444190
[TBL] [Abstract][Full Text] [Related]
13. Characterization of type A and type B CCK receptor binding sites in rat vagus nerve.
Corp ES; McQuade J; Moran TH; Smith GP
Brain Res; 1993 Sep; 623(1):161-6. PubMed ID: 8221086
[TBL] [Abstract][Full Text] [Related]
14. Modulation of cholecystokinin activity by albumin.
Huang SC; Talkad VD; Fortune KP; Jonnalagadda S; Severi C; Delle Fave G; Gardner JD
Proc Natl Acad Sci U S A; 1995 Oct; 92(22):10312-6. PubMed ID: 7479774
[TBL] [Abstract][Full Text] [Related]
15. Photoaffinity labeling of rat pancreatic cholecystokinin type A receptor antagonist binding sites demonstrates the presence of a truncated cholecystokinin type A receptor.
Poirot SS; Escrieut C; Dufresne M; Martinez J; Bouisson M; Vaysse N; Fourmy D
Mol Pharmacol; 1994 Apr; 45(4):599-607. PubMed ID: 8183238
[TBL] [Abstract][Full Text] [Related]
16. [3H]PD 140376: a novel and highly selective antagonist radioligand for the cholecystokininB/gastrin receptor in guinea pig cerebral cortex and gastric mucosa.
Hunter JC; Suman-Chauhan N; Meecham KG; Dissanayake VU; Hill DR; Pritchard MC; Kneen CO; Horwell DC; Hughes J; Woodruff GN
Mol Pharmacol; 1993 Apr; 43(4):595-602. PubMed ID: 8474432
[TBL] [Abstract][Full Text] [Related]
17. Characterization of cholecystokinin receptors on guinea pig gastric chief cell membranes.
Matozaki T; Sakamoto C; Nagao M; Nishisaki H; Konda Y; Nakano O; Matsuda K; Wada K; Suzuki T; Kasuga M
Biochem Biophys Res Commun; 1991 Feb; 174(3):1055-63. PubMed ID: 1996975
[TBL] [Abstract][Full Text] [Related]
18. Characterization of cholecystokinin receptors and messenger RNA expression in rat pancreas: evidence for expression of cholecystokinin-A receptors but not cholecystokinin-B (gastrin) receptors.
Zhou W; Povoski SP; Bell RH
J Surg Res; 1995 Mar; 58(3):281-9. PubMed ID: 7533864
[TBL] [Abstract][Full Text] [Related]
19. Gastrin13 and the C-terminal octapeptide of cholecystokinin are differently coupled to G-proteins in guinea-pig brain membranes.
Lallement JC; Galleyrand JC; Lima-Leite AC; Fulcrand P; Martinez J
Eur J Pharmacol; 1994 May; 267(3):297-305. PubMed ID: 8088368
[TBL] [Abstract][Full Text] [Related]
20. Characterization of CCKA receptor mediated pepsinogen secretion in porcine chief cells.
Meyer G; Beinborn M; Sewing KF
Pharmacology; 1996 Jul; 53(1):48-59. PubMed ID: 8875601
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]